All In Biotech

Drug Trial Radar · NCT03829241

Randomized Trial of Adult Participants With Generalized Anxiety Disorder

A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: May 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 881 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

881

Actual

Start

Feb 19, 2019

Primary completion

Jan 14, 2020

Study completion May 8, 2020

Sponsor

Lead sponsor
Biohaven Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Feb 4, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy of troriluzole versus placebo in participants with generalized anxiety disorder.

Conditions

  • Generalized Anxiety Disorder

Interventions

  • TroriluzoleDrug

    100 mg capsule

  • PlaceboDrug

    Placebo matched to troriluzole

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the HAM-A Total Score at Week 8Time frame: Baseline, Week 8

Locations

53 sites in 1 country. Site status is shown where the registry gives one.

  • Woodland International Research Group

    Little Rock, Arkansas

  • Axiom Research, LLC

    Colton, California

  • Pharmacology Research Institute

    Encino, California

  • University of California, San Francisco-Fresno

    Fresno, California

  • Collaborative Neuroscience Network, LLC.

    Garden Grove, California

  • Synergy San Diego

    Lemon Grove, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • CalNeuro Research Group

    Los Angeles, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Pacific Research Partners, LLC

    Oakland, California

  • NRC Research Institute

    Orange, California

  • Desert Valley Research

    Rancho Mirage, California

  • Atemis Institute for Clinical Research

    San Marcos, California

  • California Neuroscience Research Medical Group, Inc

    Sherman Oaks, California

  • CNS Network

    Torrance, California

  • Pacific Clinical Research Medical Group

    Upland, California

  • Child Study Center at Yale University School of Medicine

    New Haven, Connecticut

  • Comprehensive Psychiatric Care

    Norwich, Connecticut

  • Meridien Research

    Bradenton, Florida

  • Gulfcoast Clinical Research Center

    Fort Myers, Florida

  • Galiz Research

    Hialeah, Florida

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Harmony Clinical Research

    North Miami Beach, Florida

  • Clinical Neuroscience Solutions, Inc

    Orlando, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • iResearch Atlanta LLC

    Decatur, Georgia

  • Northwest Behavioral Research Center

    Marietta, Georgia

  • Phoenix Medical Research

    Prairie Village, Kansas

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • Boston Clinical Trials

    Boston, Massachusetts

  • BTC of New Bedford

    New Bedford, Massachusetts

  • Altea Research Institute

    Las Vegas, Nevada

  • Center for Emotional Fitness

    Cherry Hill, New Jersey

  • Albuquerque Neuroscience Inc.

    Albuquerque, New Mexico

  • SPRI Clinical Trials, LLC

    Brooklyn, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • New Hope Clinical Research

    Charlotte, North Carolina

  • Midwest Clinical Research Center

    Dayton, Ohio

  • IPS Research Company

    Oklahoma City, Oklahoma

  • Summit Research Network (Oregon) Inc.

    Portland, Oregon

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.